Stay updated on CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.

Latest updates to the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check7 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the CAD106 and CNP520 Alzheimer’s prevention study, including its study details, outcomes, eligibility criteria, locations, and supporting documents.SummaryDifference100%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH notice appears above the page, announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAD106 and CNP520 in At-Risk Alzheimer's Clinical Trial page.